Medical Weight Loss for Santa Fe, New Mexico Residents
Santa Fe, New Mexico residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Santa Fe through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Santa Fe Residents Choose New Hope Weight Loss
Santa Fe patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across New Mexico and beyond since 2020.
Santa Fe is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Santa Fe patients at home.
Santa Fe is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout Downtown, the Plaza, Canyon Road, and the greater northern New Mexico area. Spanish-speaking Santa Fe patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Our telehealth model serves Santa Fe and communities across New Mexico with the same flat pricing and the same supervising physician. Compounded medication arrives in discreet, cold-pack packaging at your Santa Fe address, usually within days.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Santa Fe patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Santa Fe
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Santa Fe address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Santa Fe
Does New Hope Weight Loss treat patients in Santa Fe?
Yes. Although the clinic is in Costa Mesa, California, we treat Santa Fe, New Mexico residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Santa Fe?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Santa Fe address in cold-pack packaging.
What do Santa Fe patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Santa Fe do you serve?
We serve patients from across Santa Fe by telehealth, including Downtown, the Plaza, Canyon Road, and the greater northern New Mexico area.
How soon can a Santa Fe patient start treatment?
Most Santa Fe patients complete the online intake in minutes and have Dr. Sharma's video review within about 48 hours. If you are a candidate and telehealth-eligible, medication ships shortly after, so many patients begin within roughly a week of starting.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Santa Fe, New Mexico by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.